|
UW Comprehensive CANCER CENTER SUPPORT
|
2P30CA014520-44
|
$4,590,130
|
$91,803
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S1
|
$250,000
|
$5,000
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S2
|
$136,232
|
$2,725
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S3
|
$75,711
|
$1,514
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S4
|
$31,772
|
$635
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
3P30CA014089-43S1
|
$40,593
|
$1,624
|
FARNHAM, PEGGY
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
5P30CA014089-43
|
$6,268,475
|
$250,739
|
FARNHAM, PEGGY
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
2P30CA060553-24
|
$6,420,169
|
$64,202
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-24S1
|
$250,000
|
$2,500
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-24S2
|
$200,000
|
$2,000
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-24S3
|
$246,169
|
$2,462
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-24S4
|
$58,383
|
$584
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The regulation of dendritic cell function by LMYC at steady state and during immune responses to cancer
|
1F31CA228240-01
|
$30,442
|
$7,611
|
ANDERSON, DAVID
|
WASHINGTON UNIVERSITY
|
|
The Incidence of Breast and other Cancers among Female Flight Attendants
|
ZIA CP010133 04077
|
$16,720
|
$334
|
Little, Mark
|
DCEG (NCI)
|
|
TAS::75 0849::TAS ADMINISTRATIVE MODIFICATION
|
261200800001E
|
$313,286,406
|
$666
|
DMITROVSKY, ETHAN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
Targetable Immune Evasion Pathways in Hodgkin Lymphoma
|
5R01CA161026-08
|
$373,399
|
$186,700
|
SHIPP, MARGARET
|
DANA-FARBER CANCER INST
|
|
Study of the Roles of SDF1 and CXCR4 in Hematopoiesis
|
ZIA BC 010782
|
$366,567
|
$91,642
|
Tosato, Giovanna
|
CCR (NCI)
|
|
Study of Structures of CCR5 and Its Interactions with CCR5 Inhibitors
|
ZIA BC 011109
|
$40,724
|
$2,036
|
Mitsuya, Hiroaki
|
CCR (NCI)
|
|
SPORE in Lymphoma
|
5P50CA126752-12
|
$2,297,796
|
$620,405
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Smartphone for molecular cancer diagnostic in Africa
|
4UH3CA202637-03
|
$973,275
|
$486,638
|
WEISSLEDER, RALPH
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Sleep Apnea in Survivors of Childhood Cancer Treated with Thoracic Radiation (APNEA
|
5R01CA215405-02
|
$603,556
|
$603,556
|
KRULL, KEVIN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
SEER, Registries, and Special Projects
|
ZIA CP010131 10560
|
$30,751
|
$3,075
|
Cahoon, Elizabeth
|
DCEG (NCI)
|
|
Research Management and Support
|
RMS ES 2018
|
$340,640,887
|
$22,000
|
N/A
|
National Institutes of Health
|
|
Regulation of transcription and tumor suppression by MTG family members
|
5R01CA178030-05
|
$364,000
|
$120,120
|
HIEBERT, SCOTT
|
VANDERBILT UNIVERSITY
|
|
Regulation of Exocytosis from Immune Cells
|
ZIA BC 011035
|
$62,190
|
$15,547
|
Roche, Paul
|
CCR (NCI)
|
|
Regulation of EBV Latency by EBNA1
|
2R01CA093606-16
|
$380,903
|
$304,722
|
LIEBERMAN, PAUL
|
WISTAR INSTITUTE
|
|
Registry linkage projects [including Scandinavia, SEER Medicare, other]
|
ZIA CP010150 10359
|
$120,247
|
$24,049
|
Engels, Eric
|
DCEG (NCI)
|
|
Radiation Oncology Branch - Radiation Clinic
|
ZID BC 010990
|
$5,352,849
|
$428,228
|
Camphausen, Kevin
|
CCR (NCI)
|
|
Radiation dose- response and second primary cancers of stomach, esophagus, and
|
ZIA CP010131 04134
|
$1,076
|
$161
|
Morton, Lindsay
|
DCEG (NCI)
|
|
Preclinical development and clinical monitoring of adoptive immune therapy
|
ZIC BC 011029
|
$364,078
|
$72,816
|
Rose, Jeremy
|
CCR (NCI)
|
|
Post-Transcriptional Regulation of Interleukin-7 Receptor Expression
|
ZIA BC 011214
|
$613,782
|
$122,756
|
Park, Jung-Hyun
|
CCR (NCI)
|
|
Pooling project of NCI and Cross-Canada studies
|
ZIA CP010119 10649
|
$80,847
|
$16,169
|
Beane Freeman, Laura
|
DCEG (NCI)
|
|
Pharmacokinetic and Pharmacodynamic Modeling of Anticancer Agents
|
ZIC BC 010548
|
$244,114
|
$48,823
|
Figg, William
|
CCR (NCI)
|
|
Optimal Antiretroviral Therapy During Bone Marrow Transplant in HIV-1 Infection
|
5K23CA177321-05
|
$161,608
|
$64,643
|
DURAND, CHRISTINE
|
JOHNS HOPKINS UNIVERSITY
|
|
Noncoding RNAs in gamma-Herpesvirus Biology and AIDS Malignancies
|
5P01CA214091-02
|
$1,312,028
|
$301,766
|
RENNE, ROLF
|
UNIVERSITY OF FLORIDA
|
|
NCI National Clinical Trials Network-Network Lead Academic Participating Sites
|
5U10CA180836-05
|
$634,699
|
$15,867
|
KINDLER, HEDY
|
UNIVERSITY OF CHICAGO
|
|
Molecularly Targeted Therapy for Lymphoma
|
5K24CA184039-05
|
$171,401
|
$34,280
|
GOPAL, AJAY
|
UNIVERSITY OF WASHINGTON
|
|
Molecular Mechanisms of Cancer Development
|
ZIC BC 011842
|
$162,782
|
$8,139
|
Pack, Svetlana
|
CCR (NCI)
|
|
Medical Oncology HIV-AIDS Clinical Research
|
ZID BC 011683
|
$226,739
|
$22,674
|
Gulley, James
|
CCR (NCI)
|
|
Medical Oncology Fellowship Program
|
ZIE BC 010843
|
$3,561,926
|
$178,096
|
Bilusic, Marijo
|
CCR (NCI)
|
|
Mechanisms of transcription factor integration at the c-myc promoter
|
ZIA SC 009144
|
$351,735
|
$35,173
|
Levens, David
|
CCR (NCI)
|
|
Lymphoma Studies
|
ZIA SC 006741
|
$564,009
|
$112,802
|
Wilson, Wyndham
|
CCR (NCI)
|
|
Lymphoma Disease Discovery and Definition
|
ZIA SC 000550
|
$561,264
|
$56,126
|
Jaffe, Elaine
|
CCR (NCI)
|
|
Low dose and low dose-rate cancer risk
|
ZIA CP010132 10681
|
$11,818
|
$1,773
|
Little, Mark
|
DCEG (NCI)
|
|
In Vivo Model of Epstein-Barr Virus Latency
|
5R01CA073507-20
|
$372,677
|
$186,339
|
LONGNECKER, RICHARD
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Improving Hospice Use for Patients with Blood Cancers
|
5K08CA218295-02
|
$173,698
|
$43,425
|
ODEJIDE, OREOFE
|
DANA-FARBER CANCER INST
|
|
Immunotoxin Therapy of Solid and Hematopoietic Tumors: Preclinical Studies
|
ZIA BC 008753
|
$1,671,202
|
$250,680
|
Pastan, Ira
|
CCR (NCI)
|
|
Immune Regulatory Roles of Suppressor Of Cytokine Signaling (SOCS) Molecules
|
ZIA BC 011215
|
$263,049
|
$26,305
|
Park, Jung-Hyun
|
CCR (NCI)
|
|
Immune reconstitution following autologous and allogeneic stem cell transplant
|
ZIC BC 010934
|
$364,078
|
$72,816
|
Rose, Jeremy
|
CCR (NCI)
|
|
IL-2:IL-15 cytokine receptor: implications for cancer therapy and vaccine
|
ZIA SC 004002
|
$1,096,433
|
$219,287
|
Waldmann, Thomas
|
CCR (NCI)
|
Total relevant funding to Hodgkins disease for this search: $13,282,652
|